All Access Articles |
- Here's Why Neurocrine Biosciences (NBIX) Is a Defensive Stock According to the Graham Test | 2026-06-03 | BIOTECHNOLOGY
- Here's Why Neurocrine Biosciences (NBIX) Is a Defensive Stock According to the Graham Test | 2025-10-30 | BIOTECHNOLOGY
- Neurocrine Biosciences Appoints Dr. Sanjay Keswani as CMO | 2025-04-04 | BIOTECHNOLOGY